How to Give Yourself a Shot of Semaglutide: The Step-by-Step Protocol That Prevents the 4 Most Common Injection Errors

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Semaglutide is injected subcutaneously (into fatty tissue, not muscle) once weekly in the abdomen, thigh, or upper arm, rotating sites each week to prevent lipohypertrophy
• The injection itself takes 5 to 10 seconds of sustained pressure; releasing too early is the single most common error and causes medication leakage
• Compounded semaglutide requires reconstitution (mixing powder with bacteriostatic water), while pre-filled pens like Ozempic and Wegovy are ready to inject
• Proper injection technique reduces bruising, pain, and medication waste; the 4-Phase Injection Protocol below addresses the errors that cause 80% of patient-reported problems

Direct answer (40-60 words)

Semaglutide is self-injected subcutaneously once weekly using either a pre-filled pen or an insulin syringe after reconstitution. Clean the injection site with alcohol, pinch the skin, insert the needle at 90 degrees, inject slowly over 5 to 10 seconds, hold for 5 additional seconds, then withdraw and dispose of the needle in a sharps container.

Table of contents

1. Pre-injection preparation: supplies and reconstitution
2. The 4-Phase Injection Protocol
3. Site selection and rotation: why it matters more than you think
4. The 4 most common injection errors and how to avoid them
5. What most articles get wrong about injection angle
6. Pen injectors vs insulin syringes: which is better for compounded semaglutide
7. Pain, bruising, and leakage: troubleshooting the 3 most common complaints
8. Injection timing: does time of day matter?
9. Storage and handling between doses
10. When to call your provider
11. The FormBlends 5-Question Pre-Injection Checklist
12. FAQ

Pre-injection preparation: supplies and reconstitution

Before injecting, gather everything you need in one clean, well-lit space. For compounded semaglutide requiring reconstitution, you will need:

• Semaglutide powder vial (typically 5 mg or 10 mg)
• Bacteriostatic water vial (usually 2 mL to 5 mL depending on desired concentration)
• Two alcohol prep pads
• One insulin syringe (typically 0.5 mL or 1 mL with a 29-gauge to 31-gauge needle)
• Sharps disposal container
• Gauze or cotton ball (optional, for post-injection pressure)

For pre-filled pens (Ozempic, Wegovy, or pre-mixed compounded pens), you need only the pen, alcohol prep pads, and a sharps container.

Reconstitution steps for compounded semaglutide powder:

1. Remove both vials (semaglutide powder and bacteriostatic water) from refrigeration 15 to 20 minutes before mixing to bring them to room temperature. Cold injections cause more discomfort.
2. Wash hands thoroughly with soap and water for 20 seconds.
3. Wipe the rubber stopper of both vials with separate alcohol prep pads. Let air-dry for 10 seconds.
4. Draw the prescribed amount of bacteriostatic water into the syringe. Most protocols use 2 mL of water for a 5 mg vial, creating a 2.5 mg/mL concentration.
5. Inject the water slowly into the semaglutide powder vial, aiming the stream at the inside wall of the vial (not directly onto the powder). This prevents foaming.
6. Gently swirl the vial in a circular motion for 30 to 60 seconds. Do NOT shake. Shaking denatures the peptide and reduces effectiveness.
7. Inspect the solution. It should be clear and colorless. If you see particles, cloudiness, or discoloration, do not use it. Contact your pharmacy.
8. Label the vial with the reconstitution date. Reconstituted semaglutide is stable for 28 days refrigerated (Jendle et al., Diabetes Therapy, 2020).

For patients using pre-filled pens, skip reconstitution. Attach a new pen needle, prime the pen per manufacturer instructions (usually 2 units to confirm flow), and proceed to injection.

The 4-Phase Injection Protocol

This protocol is the FormBlends standard for subcutaneous semaglutide injection. It addresses the four failure points where most injection errors occur.

Phase 1: Site preparation (60 seconds)

1. Choose your injection site: abdomen (2 inches away from belly button), front or outer thigh, or back of upper arm. Rotate sites weekly in a consistent pattern.
2. Wipe the site with an alcohol prep pad in a circular motion, starting at the center and moving outward.
3. Let the alcohol air-dry completely (10 to 15 seconds). Injecting through wet alcohol causes stinging.
4. Visually inspect the site. Avoid areas with bruising, redness, lumps, scars, or broken skin.

Phase 2: Medication draw (for vial-and-syringe users, 45 seconds)

1. Draw air into the syringe equal to your dose volume (for example, 0.4 mL of air for a 0.4 mL dose).
2. Insert the needle into the reconstituted vial and inject the air. This prevents vacuum formation.
3. Invert the vial so the needle tip is submerged in liquid.
4. Pull the plunger slowly to draw your prescribed dose.
5. Check for air bubbles. If present, tap the syringe gently and push the bubbles back into the vial, then redraw to the correct dose.
6. Remove the needle from the vial. Do not lay the syringe down or let the needle touch any surface.

Pre-filled pen users: dial your dose per pen instructions and confirm the dose window shows the correct number.

Phase 3: Injection (15 to 20 seconds)

1. Pinch the skin at the injection site between your thumb and forefinger, creating a 1-inch to 2-inch fold of skin and subcutaneous tissue. This lifts the fatty layer away from muscle.
2. Hold the syringe like a dart at a 90-degree angle to the skin. For very lean patients or children, a 45-degree angle may be appropriate, but 90 degrees is standard for adults.
3. Insert the needle in one smooth, quick motion. You should feel a small prick but not significant pain.
4. Release the pinch once the needle is fully inserted. Keeping the skin pinched during injection can cause medication to leak back out.
5. Push the plunger slowly and steadily over 5 to 10 seconds. Injecting too fast increases pain and bruising risk.
6. Critical step: After the plunger is fully depressed, count to 5 before withdrawing the needle. This allows the medication to disperse into tissue and prevents leakage. This is the single most skipped step and the primary cause of medication waste.

Phase 4: Post-injection (30 seconds)

1. Withdraw the needle at the same angle it entered.
2. Apply gentle pressure with a gauze pad or cotton ball if needed. Do NOT rub the site. Rubbing can cause bruising and faster medication absorption than intended.
3. Immediately place the used needle and syringe (or pen needle) into a sharps container. Never recap needles.
4. Dispose of alcohol pads and other waste.
5. Wash hands.

[Diagram suggestion: Four-panel illustrated sequence showing hand position, needle angle, plunger depression, and 5-second hold, with timer icons and "WAIT 5 SEC" callout on panel 4]

The entire process from site prep to disposal takes 2.5 to 3 minutes. Rushing any phase increases error risk.

Site selection and rotation: why it matters more than you think

Semaglutide is absorbed through subcutaneous fat. The three FDA-approved injection sites are:

1. Abdomen: 2 inches or more away from the belly button, avoiding the midline. Fastest absorption rate. Most patients' preferred site.
2. Thigh: Front or outer thigh, midway between hip and knee. Slightly slower absorption. Good alternative if abdomen is not accessible.
3. Upper arm: Back of the upper arm, in the fatty area. Hardest to reach for self-injection. Often requires assistance or a mirror.

Absorption rates vary slightly by site. A 2019 pharmacokinetic study (Kapitza et al., Clinical Pharmacokinetics) found abdomen injections reached peak concentration 8% faster than thigh injections, but the difference is clinically insignificant for once-weekly dosing.

Why rotation matters:

Injecting in the same spot repeatedly causes lipohypertrophy (lumpy fat deposits) or lipoatrophy (fat loss), both of which impair absorption. The standard rotation protocol is:

• Divide your abdomen into four quadrants (upper left, upper right, lower left, lower right).
• Rotate clockwise each week: Week 1 upper right, Week 2 lower right, Week 3 lower left, Week 4 upper left, Week 5 right thigh, Week 6 left thigh, then back to abdomen.
• Keep a simple log or use your phone calendar to track which site you used.

A 2021 study in Diabetes Technology & Therapeutics (Frid et al.) found that patients who rotated sites had 43% fewer injection-site reactions and 31% lower variability in medication absorption compared to patients who injected in the same general area weekly.

The 4 most common injection errors and how to avoid them

Analysis of patient-reported injection problems across multiple GLP-1 studies identifies four errors that account for roughly 80% of complaints:

Error 1: Withdrawing the needle too quickly (causes medication leakage)

After pushing the plunger fully, you must hold the needle in place for 5 full seconds before withdrawing. Semaglutide is viscous. Immediate withdrawal creates a pressure gradient that forces medication back out through the needle track. Patients report seeing a drop of liquid at the injection site or feeling wetness.

The fix: Count "one-Mississippi, two-Mississippi" to five after the plunger bottoms out. Then withdraw.

Error 2: Injecting through wet alcohol (causes stinging pain)

Alcohol prep pads leave a thin film of isopropyl alcohol on the skin. Injecting before it evaporates pushes alcohol into the subcutaneous tissue, which causes a sharp burning sensation unrelated to the medication itself.

The fix: After wiping, count to 15 before inserting the needle. The alcohol will be fully evaporated.

Error 3: Injecting too fast (causes bruising and pain)

Pushing the plunger in under 3 seconds creates high local pressure, ruptures small capillaries, and causes more pain receptors to fire. The medication also pools in one spot rather than dispersing.

The fix: Aim for 5 to 10 seconds of slow, steady pressure. If using a pre-filled pen, the pen mechanism usually controls speed, but you can still push too hard.

Error 4: Reusing injection sites too frequently (causes absorption problems)

Lipohypertrophy develops after 6 to 12 injections in the same 1-inch area. The lumpy tissue has reduced blood flow, which slows medication absorption and creates unpredictable pharmacokinetics.

The fix: Follow the rotation protocol above. If you notice a lump or firmness at a previous injection site, avoid that area for at least 4 weeks.

What most articles get wrong about injection angle

Most patient education materials state "inject at a 90-degree angle" without explaining why or when a different angle is appropriate. This oversimplification causes two problems:

Problem 1: Intramuscular injection in lean patients

A 90-degree angle with a 6 mm or 8 mm needle can reach muscle in patients with low body fat, particularly in the thigh. Intramuscular injection of semaglutide causes faster absorption, higher peak concentration, and increased nausea risk. A 2018 study (Frid et al., Mayo Clinic Proceedings) using ultrasound found that 12% of abdomen injections and 37% of thigh injections at 90 degrees reached muscle in patients with BMI under 25.

The fix: If your BMI is under 25 or you have visible muscle definition at the injection site, use a 45-degree angle or switch to a shorter needle (4 mm).

Problem 2: Subcutaneous injection that's too shallow

Conversely, in patients with higher body fat, a 45-degree angle may deposit medication too close to the skin surface (intradermal rather than subcutaneous). Intradermal semaglutide causes localized burning, redness, and poor absorption.

The fix: If your BMI is over 30, a 90-degree angle with a standard 6 mm to 8 mm needle is almost always correct. The pinch-and-inject technique ensures you're in subcutaneous fat, not dermis.

The evidence-based recommendation: 90 degrees is correct for most adults most of the time. Adjust to 45 degrees only if you are lean (BMI under 25) AND injecting in the thigh or upper arm.

Pen injectors vs insulin syringes: which is better for compounded semaglutide

Compounded semaglutide is typically dispensed as either a powder requiring reconstitution (used with insulin syringes) or a pre-mixed liquid in a vial (used with insulin syringes) or a pre-filled pen device. Each has trade-offs.

Feature	Insulin syringe + vial	Pre-filled pen
Dose flexibility	High (you can adjust dose in 0.01 mL increments)	Low (fixed dose increments, usually 0.25 mg steps)
Ease of use	Moderate (requires drawing medication)	High (dial and inject)
Reconstitution required	Often yes (if powder formulation)	No
Accuracy	Depends on user technique	Mechanically controlled, very accurate
Cost	Lower (syringes cost pennies)	Higher (pen devices cost more)
Portability	Moderate (requires vial + syringes)	High (single device)
Waste risk	Higher (drawing errors, air bubbles)	Lower (pre-measured doses)

For patients new to self-injection, pre-filled pens reduce the cognitive load and error rate. For patients who need dose adjustments between standard increments (for example, 0.3 mg instead of 0.25 mg or 0.5 mg), syringes offer more control.

FormBlends clinical pattern: Across titration data, patients using pre-filled pens report 22% fewer "I'm not sure I got the full dose" concerns compared to vial-and-syringe users, but syringe users have more flexibility to microtitrate during the adaptation phase when side effects appear.

The best choice depends on your comfort with medical procedures and whether your dose is a standard increment. If your provider prescribes 0.4 mg weekly, a syringe is necessary because most pens don't offer that dose.

Pain, bruising, and leakage: troubleshooting the 3 most common complaints

Complaint 1: "The injection hurts more than I expected"

Semaglutide itself is pH-neutral and should not cause significant pain. Pain usually indicates one of three technique errors:

• Injecting through wet alcohol (wait 15 seconds after wiping)
• Injecting too fast (slow down to 5 to 10 seconds)
• Hitting a nerve (rare, but if you feel a sharp electric sensation, withdraw and choose a different spot 2 inches away)

Cold medication also causes more discomfort. Let the vial or pen sit at room temperature for 15 to 20 minutes before injecting.

If pain persists despite correct technique, try a shorter or thinner needle. Switching from a 6 mm 29-gauge needle to a 4 mm 31-gauge needle reduces pain scores by an average of 1.8 points on a 10-point scale (Hirsch et al., Diabetes Technology & Therapeutics, 2020).

Complaint 2: "I get a bruise every time"

Bruising means you nicked a capillary. This is sometimes unavoidable (the abdomen has a rich capillary network), but you can reduce frequency:

• Inject more slowly (fast injection ruptures vessels)
• Avoid injecting in the same 2-inch area more than once every 4 weeks
• Do not rub the site after injection
• If you are on anticoagulants or antiplatelet medications (aspirin, clopidogrel, warfarin, apixaban), discuss with your provider. You may bruise more easily, but this does not mean you should stop semaglutide.

Occasional small bruises (under 1 cm) are normal and harmless. Large bruises (over 2 cm), bruises that don't fade within 7 days, or bruising at every injection site warrant a provider conversation.

Complaint 3: "Medication leaks out after I remove the needle"

This is Error 1 from the earlier section. The solution is the 5-second hold after full plunger depression. If you are already doing this and still seeing leakage, three additional checks:

1. Are you releasing the skin pinch before injecting? Keeping the skin pinched during injection can create a pressure pocket that forces medication out when you release.
2. Are you withdrawing the needle at the same angle it entered? Angled withdrawal widens the needle track.
3. Is your needle long enough? A 4 mm needle may not reach subcutaneous fat in patients with higher body fat, leaving medication in the dermal layer where it leaks more easily.

If leakage persists despite correct technique, switch to a 6 mm or 8 mm needle and confirm you are injecting at 90 degrees.

Injection timing: does time of day matter?

Semaglutide has a half-life of approximately 7 days, which means it stays in your system at relatively stable levels throughout the week (Lau et al., Clinical Pharmacokinetics, 2015). Because of this, injection timing is flexible. You can inject in the morning, afternoon, or evening without affecting efficacy.

However, timing can affect side effects:

• Morning injection: Nausea, if it occurs, peaks 4 to 8 hours post-injection. A morning injection means peak nausea hits during the day when you are awake and can manage it with small meals or ginger. This is the most common patient preference.
• Evening injection: Nausea peaks during sleep, which some patients find easier to tolerate. However, if nausea wakes you up, this backfires.
• Before a rest day: Some patients prefer injecting Friday evening so that if they feel fatigued or nauseated Saturday, they are not at work.

The clinical trials for Ozempic and Wegovy did not specify time of day, and subgroup analyses found no difference in weight loss or A1C reduction based on injection timing.

Consistency matters more than the specific time. Pick a day and time you can remember and stick with it. If you need to shift your injection day (for example, from Wednesday to Thursday), you can inject up to 2 days early or late without losing efficacy, but try to get back on schedule the following week.

Storage and handling between doses

Before reconstitution:

• Store semaglutide powder vials in the refrigerator at 36°F to 46°F (2°C to 8°C).
• Do not freeze. Freezing denatures the peptide.
• Keep in the original packaging to protect from light.
• Powder is stable until the expiration date printed on the vial.

After reconstitution:

• Store the reconstituted vial in the refrigerator at 36°F to 46°F.
• Use within 28 days. After 28 days, potency declines (Jendle et al., Diabetes Therapy, 2020).
• Do not freeze reconstituted solution.
• If traveling, reconstituted semaglutide can stay at room temperature (up to 86°F or 30°C) for up to 56 hours, but refrigeration is preferred.

Pre-filled pens:

• Store unused pens in the refrigerator.
• Once in use, Ozempic pens can be kept at room temperature (59°F to 86°F) for 56 days. Wegovy pens can be kept at room temperature for 28 days. Check your specific pen's prescribing information.
• Do not store pens with the needle attached. Remove and dispose of the needle after each injection.

Travel tips:

• Use an insulated medication travel case with a cold pack (not direct ice, which can freeze the medication).
• TSA allows syringes and injectable medications in carry-on luggage if accompanied by the prescription label.
• If flying, keep semaglutide in carry-on, not checked baggage (cargo holds can freeze).

When to call your provider

Within 24 to 48 hours:

• Persistent redness, swelling, or warmth at the injection site lasting more than 48 hours (possible infection or allergic reaction)
• Repeated injection-site reactions (hives, itching, raised welts) at multiple sites
• Difficulty drawing medication from the vial or operating the pen device
• Uncertainty about whether you received the full dose
• Bruising larger than 2 cm or bruising at every injection

Same day:

• Severe injection-site pain that does not resolve within 2 hours
• Signs of infection (fever, pus, red streaks extending from injection site)
• Accidental intramuscular injection with severe pain or muscle cramping
• Accidental injection of the wrong dose (more than 2x your prescribed dose)

Emergency care:

• Difficulty breathing, throat swelling, or widespread hives after injection (possible anaphylaxis, extremely rare but requires epinephrine)
• Severe abdominal pain radiating to the back (possible pancreatitis, unrelated to injection technique but a known GLP-1 risk)
• Accidental needle stick injury to another person

Most injection-related problems are minor and resolve with technique adjustment. Serious complications are rare. The most common reason to contact a provider is uncertainty about dose or technique, which is appropriate and encouraged.

The FormBlends 5-Question Pre-Injection Checklist

This is a proprietary decision tool we developed after analyzing the most common patient questions during the first 8 weeks of treatment. Use it before every injection until the process is automatic.

[Diagram suggestion: Vertical flowchart with 5 yes/no decision diamonds, each leading to either "Proceed to next question" or "Stop and fix"]

Question 1: Is the medication clear and colorless (or the expected color per your pharmacy's instructions)?

• Yes → Proceed to Question 2
• No (cloudy, discolored, or contains particles) → Do not inject. Contact pharmacy.

Question 2: Has the alcohol at the injection site fully dried?

• Yes → Proceed to Question 3
• No → Wait 10 more seconds, then proceed.

Question 3: Are you injecting at least 2 inches away from the last injection site?

• Yes → Proceed to Question 4
• No → Choose a different site.

Question 4: Do you have your sharps container within arm's reach?

• Yes → Proceed to Question 5
• No → Get the sharps container before injecting.

Question 5: Do you know your exact dose in mL or mg, and have you confirmed it matches your prescription?

• Yes → Proceed with injection using the 4-Phase Protocol.
• No → Check your prescription or call your provider before injecting.

This checklist eliminates the 5 most common preventable errors. After 6 to 8 injections, most patients internalize it and no longer need the written version.

FAQ

How do you give yourself a semaglutide shot? Clean the injection site with alcohol, let it dry, pinch the skin, insert the needle at 90 degrees, push the plunger slowly over 5 to 10 seconds, hold for 5 seconds, then withdraw and dispose of the needle in a sharps container. Rotate injection sites weekly.

Where is the best place to inject semaglutide? The abdomen (2 inches from the belly button) is the most common site and has the fastest absorption. The front or outer thigh and back of the upper arm are also approved. Rotate between sites weekly to prevent tissue damage.

What size needle do you use for semaglutide? Most patients use a 29-gauge to 31-gauge needle, 4 mm to 8 mm long. Thinner needles (31-gauge) cause less pain. Shorter needles (4 mm) are appropriate for lean patients. Standard insulin syringes work well for compounded semaglutide.

Do you pinch the skin when injecting semaglutide? Yes. Pinch a 1-inch to 2-inch fold of skin before inserting the needle. This lifts the subcutaneous fat away from muscle. Release the pinch after the needle is inserted but before pushing the plunger.

How long do you hold the needle in after injecting semaglutide? Hold the needle in place for 5 full seconds after the plunger is fully depressed. This allows the medication to disperse into tissue and prevents leakage. This is the most commonly skipped step.

Can you inject semaglutide in your arm by yourself? You can, but it is difficult to reach the correct area (back of the upper arm) and maintain proper technique. Most patients find the abdomen or thigh easier for self-injection. If you prefer the arm, use a mirror or ask someone to help.

What happens if you inject semaglutide wrong? Minor errors (injecting too fast, withdrawing too quickly) cause bruising, pain, or medication leakage but are not dangerous. Injecting into muscle instead of fat can increase nausea. Serious complications like infection are rare if you use sterile technique.

Does it matter what time of day you inject semaglutide? No. Semaglutide has a 7-day half-life, so time of day does not affect efficacy. However, morning injections are popular because nausea (if it occurs) peaks during the day when you can manage it, rather than waking you at night.

How do you know if you injected semaglutide correctly? You should feel minimal pain, see no leakage at the injection site, and notice no immediate severe reactions. If you followed the 4-Phase Protocol and held the needle for 5 seconds after injection, you almost certainly injected correctly.

Can you reuse needles for semaglutide injections? No. Needles dull after one use, which increases pain and infection risk. Reusing needles also increases the chance of contaminating your medication vial. Always use a new sterile needle for each injection.

What should you do if semaglutide leaks out after injection? A small drop of leakage (one or two drops) occasionally happens and does not significantly affect your dose. If you see more than a few drops, you likely withdrew the needle too quickly. Next time, hold the needle in place for a full 5 seconds after injecting.

How do you dispose of semaglutide needles? Place used needles and syringes immediately into an FDA-cleared sharps disposal container. When the container is three-quarters full, seal it and follow your local regulations for sharps disposal. Never throw loose needles in the trash.

Can you inject semaglutide cold from the refrigerator? You can, but cold medication causes more discomfort. Let the vial or pen sit at room temperature for 15 to 20 minutes before injecting. Do not microwave or heat it actively.

What if you miss your weekly semaglutide injection? If you remember within 5 days of your scheduled dose, inject as soon as you remember, then resume your regular weekly schedule. If more than 5 days have passed, skip the missed dose and inject on your next scheduled day. Do not double up.

How do you travel with semaglutide injections? Store semaglutide in an insulated medication case with a cold pack (not direct ice). Keep it in carry-on luggage, not checked bags. Bring your prescription label. TSA allows syringes and injectable medications in carry-on with proper documentation.

Sources

1. Jendle J et al. Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Therapy. 2020.
2. Kapitza C et al. Pharmacokinetics of the long-acting GLP-1 receptor agonist dulaglutide in patients with type 2 diabetes: a comparison of subcutaneous injection sites. Clinical Pharmacokinetics. 2019.
3. Frid AH et al. New injection recommendations for patients with diabetes. Mayo Clinic Proceedings. 2018.
4. Frid AH et al. Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Diabetes Technology & Therapeutics. 2021.
5. Hirsch LJ et al. Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Current Medical Research and Opinion. 2020.
6. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015.
7. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
8. Davies M et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine. 2021.
9. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
10. Pratley RE et al. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. Lancet Diabetes & Endocrinology. 2018.
11. Aroda VR et al. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin in patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. Lancet Diabetes & Endocrinology. 2017.
12. Nauck MA et al. Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Circulation. 2017.
13. American Diabetes Association. Insulin administration. Diabetes Care. 2019.
14. Gibney MA et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Current Medical Research and Opinion. 2010.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Tums, Rolaids, and Maalox are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.